pancreatic neuroendocrine tumors (PNETs)
Showing 1 - 25 of >10,000
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Multi-dimensional Fragmentomic Assay for Early Detection of
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Fragmentomic profiles of plasma cfDNA
- (no location specified)
Apr 27, 2023
Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)
Recruiting
- Multiple Endocrine Neoplasia Type 1
- Pancreatic Neuroendocrine Tumor
- EUS-guided fine-needle injection
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 24, 2022
Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning
Recruiting
- Nonfunctional Pancreatic Neuroendocrine Tumor
- +2 more
- EUS-guided ethanol ablation
- EUS-guided lauromacrogol ablation
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 30, 2022
Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail
Recruiting
- Non Functioning Pancreatic Endocrine Tumor
- Histopathological review, long-term prognosis and quality of life follow-up
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Jun 8, 2023
Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 Trial in Marseille (Radiofrequency ablation)
Recruiting
- Neuroendocrine Tumor of Pancreas (Disorder)
- Neuroendocrine Tumor Grade 1
- Radiofrequency ablation
-
Marseille, FranceInstitut Paoli Calmettes
Jan 5, 2022
Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- Unresectable Pancreatic Neuroendocrine Carcinoma
- Lutetium Lu 177 Dotatate
- +4 more
- (no location specified)
Feb 10, 2022
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
- long-acting Octreotide.
- (no location specified)
May 22, 2023
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- (no location specified)
Oct 16, 2023
Development of New Personalised 3D Preclinical Models of
Recruiting
- Pancreatic Neuroendocrine Tumor
-
Milan, MI, ItalyIRCCS San Raffele Institute
Nov 2, 2023
Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- +4 more
-
Ames, Iowa
- +5 more
Dec 3, 2021
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)
Recruiting
- Pancreatic Neuroendocrine Tumor
- peptide receptor radionuclide therapy with Y-90-DOTATOC
-
Milano, Italy
- +1 more
Sep 30, 2022
Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)
Not yet recruiting
- Neuroendocrine Tumors
- +4 more
-
Newport Beach, California
- +2 more
Aug 16, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023
Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic
Recruiting
- Hepatocarcinoma
- Pancreatic Tumor
- Hepatocellular carcinoma
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 20, 2023
Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- +4 more
- Biospecimen Collection
- +5 more
- (no location specified)
Jan 14, 2023
Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Pancreas Cancer
- cytoreductive surgery
- +2 more
-
Chicago, IllinoisThe University of Chicago
Nov 8, 2022
Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)
Recruiting
- Neuroendocrine Tumor Grade 3
- +2 more
-
Tianjin, Tianjin, ChinaRui Liu
Nov 17, 2022
Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)
Active, not recruiting
- Carcinoid Tumor
- Pancreatic Neuroendocrine Tumor
-
Boston, Massachusetts
- +1 more
Jul 15, 2022
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,
Recruiting
- Neuroendocrine Tumors
- +4 more
- [212Pb] VMT-α-NET
- [203Pb] VMT-α-NET SPECT/CT
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023
Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided
Recruiting
- Neuroendocrine Tumor of Pancreas
- Multiple Endocrine Neoplasia Type 1
- High-dose-high precision MR-guided radiotherapy
-
Utrecht, NetherlandsUMC Utrecht
May 29, 2022
Genetic Predisposition Testing Program for Pancreatic
Not yet recruiting
- Pancreatic Neuroendocrine Neoplasm
- Hereditary Cancer Panel
-
Los Angeles, California
- +2 more
Feb 17, 2023